.png){kind=icon}
N
Nima Ghalehsari
H指数:5
被引数:318
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis
移植后环磷酰胺（PTCy）为基础的预防措施与非PTCy预防措施后的慢性移植物抗宿主病
Blood Advances
IF7.1
A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma
一种新型无严重毒性、无进展生存期终点的预测指标可预测CD19嵌合抗原受体-T细胞疗法在大型B细胞淋巴瘤中的治疗效果
Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS
早期使用糖皮质激素和Anakinra管理Axicabtagene ciloleucel毒性的总CRS和ICANS持续时间减少
Blood Advances
IF7.1
Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States
理解多样性：ASTCT-NMDP ACCESS计划对美国造血细胞移植与细胞治疗从业人员的一项调查
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+selected Cells [Haplo-Cord] Versus Matched Donors)
骨髓纤维化的移植结果: 供体类型的影响 (由CD34选择的细胞 [haplo-cord] 支持的脐带血移植物与匹配的供体)
Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
免疫检查点抑制剂在胃肠道恶性肿瘤中的作用
